Considering that metastatic melanomas are frequently characterized by BRAF V600E heterozygous mutation,25 we assessed its role on c-FOS stability by transiently transfecting BRAF V600E in the early primary Me1007 cell line, endogenously expressing wild-type BRAF. This evidence concerns the gene FOS and metastatic melanoma.